Oops! [Two-Stage / GS Designs]

posted by ElMaestro  – Denmark, 2011-02-07 18:06 (5613 d 05:59 ago) – Posting: # 6571
Views: 31,415

Hi HS,

❝ Sure. I’m a little bit confused right now, because it seems that I misunderstood the decision procedure. Until you came up with your nice question I thought that the power calculation is done on the actual PE of stage 1 (1.08, not 0.95) and only the sample size calculation is done with 0.95 (no adaption for effect size). From the examples the former is not true – both are done with 0.95. Now I’m stuck. Potvin’s simulations were done with 0.95; is it that simple to use e.g. 0.90 instead?


I am no expert here at all.
My impression was that ordinarily a semi-blinded review of the data is done where the apparent variation is calculated and used given an assumption of the PE. I always thought about it like Heisenberg's uncertainty principle. You can't know both the PE and the CV at the interim stage.
If the PE (even though not calculated) actually deviates a lot from the assumption, then the apparent CV becomes large.

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
114 visitors (0 registered, 114 guests [including 10 identified bots]).
Forum time: 01:06 CEST (Europe/Vienna)

Science is simply common sense at its best that is,
rigidly accurate in observation, and
merciless to fallacy in logic.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5